
karen (appleton) page
1.6K posts

karen (appleton) page
@karenappleton
GP at B Capital. Exec @ Box, Apple, Prosper.


Emails and other documents show that Epstein was in contact with at least 20 prominent tech executives, investors and researchers, including some current CEOs, according to an NBC News review of a portion of the documents. nbcnews.com/tech/tech-news…

Reed explains that the job of a board member is not to add value or give advice. It is to replace the CEO: "If the company falls apart, I will be part of replacing the CEO. That's basically the entire job. To have the confidence to do that, you have to learn the business. Board members are not here to add value. They can hire consultants who know the industry and are not conflicted for advice. So I shouldn't spend my time trying to give advice. So then what am I doing? I'm here as a board member as an insurance layer. Don't measure yourself by did you give a suggestion? Measure yourself by did you get more prepared for the small chance that you will have to take big action."












2,850 days. Almost 8 years. That's how long it took to save a life. In August of 2016 my @firstround partner, @btrenchard, led @OssiumHealth's Seed round. And in May of 2024, a 68 year-old woman in Michigan became the first patient to receive a bone marrow transplant from a deceased donor. When she was not able to find a bone marrow match from a living donor, she enrolled in Ossium's PRESERVE I clinical trial -- and matched with bone marrow stored in at Ossium's biobank (the only bone marrow biobank in the world). Until now, every time an organ donor died, their bone marrow was discarded. Thrown away. Regardless of whether there was a cancer patient who was a genetic match and desperately needed that bone marrow. Ossium figured out how to collect, process and cryopreserve bone marrow from deceased organ donors. Their network of 27 organ procurement organizations recovers bone marrow from organ donors and transports it to Ossium's facility where the company processes and manufactures the doses for the patients -- and cryopreserves it in their biobank. Before Ossium it typically took months to find a living bone marrow donor who is: a) a genetic match, b) healthy enough, and c) willing to donate. And those are months that a blood cancer patient often doesn't have. Today there is a woman in Michigan who is alive -- and on a great recovery trajectory from her blood cancer, because Ossium had a bone marrow unit that could match her and save her life. Congrats to Kevin Caldwell and the entire Ossium team. We can't wait to see the impact you have over the next 2,850 days. More info here: foxnews.com/health/leukemi…













